Topic: Tepnel Lif Date: 5/7/2008 Author: trader Subject: Positiive News Body: Positive news Tepnel preferred supplier agreement with AstraZeneca for DNA extraction services is extended. The Share price responded by trading up 0.75p to 6.00p since the announcement. Now I understand why AXA S. A , Holds 27,732,428 shares in the company./   Cancel